[1]Amelia R, Sari Wahyuni A, Yunanda Y, et al. Atherosclerotic cardiovascular disease in diabetes patients[J]. Curr Diabetes Rev, 2023, 19: 62-69. [2]李沛城, 冯波. 利拉鲁肽下调糖尿病 ApoE-/小鼠主动脉糖基化终产物受体表达并减轻动脉粥样硬化[J]. 中华内分泌代谢杂志, 2016, 32: 680-684. [3]Jakhar DK, Vishwakarma VK, Singh R, et al. Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials[J]. Int J Pharm, 2023, 634: 122585.doi:doi: 10.1016/j.ijpharm.2023.122585. [4]Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles[J]. Nat Rev Clin Oncol, 2023, 20: 33-48. [5]Chen L, Zhou Z, Hu C, et al. Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy[J]. Research, 2022, 2022:1-12.doi:doi: 10.34133/2022/9845459. [6]郭方君, 杨人强. 血小板微粒促进动脉粥样硬化发生的研究进展[J]. 基础医学与临床, 2020, 40:1551-1555. [7]Mei D, Gong L, Zou Y, et al. Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy[J]. J Control Release, 2020, 324: 341-353. [8]Becker PH, Thérond P, Gaignard P. Targeting mitochondrial function in macrophages: a novel treatment strategy for atherosclerotic cardiovascular disease?[J]. Pharmacol Ther, 2023, 247: 108441. [9]张文婷, 王瑾, 岳继萍, 等. 硫氧还蛋白相互作用蛋白降低GLP-1促小鼠胰岛β细胞的增殖效应[J]. 基础医学与临床, 2020, 40:1076-1082. [10]刘东华, 荆凡波, 全香花, 等. 基因多态性与胰高血糖素样肽1受体激动剂疗效的相关性研究进展[J]. 中国药房, 2020, 31: 245-250. [11]Wronka M, Krzemińska J, Mlłynarska E, et al. New insights into the use of liraglutide—impact on cardiovascular risk and microvascular outcomes[J]. Biomedicines, 2023, 11: 1159-1175. [12]刘滔滔, 李天容, 王雪, 等. 纳米颗粒和外泌体靶向载药系统诊治动脉粥样硬化的机遇与挑战[J].中国全科医学, 2023, 26: 903-910. [13]Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery[J]. Nat. Biotechnol, 2015, 33: 941-951. [14]Lim GB. Pro-inflammatory atherogenic role of platelets[J]. Nat Rev Cardiol, 2020, 17: 6-7. [15]Ferreira-Faria I, Yousefiasl S, Macário-Soares A, et al. Stem cell membrane-coated abiotic nanomaterials for biomedical applications[J]. J Control Release, 2022, 351: 174-197. |